Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Vitreoretinal surgery · Tennessee | Vitreoretinal surgery · Texas | |
|---|---|---|
| Surgeons, 2024 | 36 | 83 |
| Medicare fee-for-service cases | 2,272 | 6,824 |
| Growth since 2019 (Medicare FFS) | −2.5%/yr | −3.6%/yr |
| Forecast cases (Medicare FFS) | 2,320 in 2030 | 7,210 in 2030 |
| Forecast growth | +0.3%/yr to 2030 | +0.9%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.3 | 3.2 |
| Medicare Advantage share | 57% | 59% |
| Out of hospital | 77% (+10 pts since 2019) | 80% (+24 pts since 2019) |
| Cases per surgeon | 63 | 82 |
| Top 10 surgeons' share | 52% | 34% |
| Surgeons growing | 5 | 11 |
| New since the base year | 5 | 12 |
| Likely to stop billing it | 1 by 2026 | 11 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $8,194 | $12K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.